AUG 6, 2026 · PHASE 3 TRIAL
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcome data are not yet available, making it an ongoing investigation rather than evidence of efficacy.
Reported
Planned enrollment4200
Study phasePhase 3
Primary outcome measureTime to first event of Cardiovascular death…